Gazette.govt.nzPursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
| Product: | Daunorubicin |
| Active Ingredient: | Daunorubicin hydrochloride 2.14mg/mL equivalent to daunorubicin 2mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer (Perth) Pty Limited, Perth, Australia |
| Note: This renewed consent is valid for two years from 26 September 2019. | |
| Product: | Fentanyl |
| Active Ingredient: | Fentanyl citrate 31.42mg/L equivalent to fentanyl 20mg/L |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Note: This renewed consent is valid for two years from 23 September 2019. | |
| Product: | Fentanyl |
| Active Ingredient: | Fentanyl citrate 15.71mg/L equivalent to fentanyl 10mg/L |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Note: This renewed consent is valid for two years from 23 September 2019. | |
Dated this 6th day of September 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).